Clinuvel Pharmaceuticals Ltd (CUVL) › Shares OutstandingClinuvel Pharmaceuticals Ltd (CUVL): Shares OutstandingAnnual figures by period end, from SEC filings.50.43MAs of 2026-06-302025-06-30: 50.12M2026-06-30: 50.43M50.43M2025-06-30 Shares Outstanding (shares) 2026-06-30Period endedShares OutstandingChange YoYSource filing2026-06-3050.43M+0.6%2026-10-30, Balance as of period end2025-06-3050.12Mn/a2026-10-30, Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesDividends PaidWeighted Average Diluted SharesEPS (Basic)